Zack Debra
Transaction: 08/03/2026
OTHER
Change
0
Price
Not reported
Filing
08/06/2026
Type
OTHER
Spero Therapeutics, Inc.
SPRO • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$71.80M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Stable or improving margins · 14.4%Positive revenue growth · 80.9%Reasonable earnings multiple · 15.23Manageable debt level · 0.05Healthy liquidity · 7.59
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:28 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$71.80M
52W Range1.08 - 3.08
Beta1.48
Gross Margin100.00%
Oper. Margin-0.04%
Profit Margin14.38%
Debt/Eq0.05
Current Ratio7.59
Quick Ratio7.59
Volume1.28M
Price$0.00
Change0.00%
Market Cap$71.80M
52W Range1.08 - 3.08
Beta1.48
Gross Margin100.00%
Oper. Margin-0.04%
Profit Margin14.38%
Debt/Eq0.05
Current Ratio7.59
Quick Ratio7.59
Volume1.28M
Avg Volume1.26M
EPS Surprise0.05
Investment DNA
How strong this company looks for long-term investors
65
out of 100
Business Quality
Margins, moat, returns
61/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
82/100
Why this score▼
Stable or improving margins · 14.4%Positive revenue growth · 80.9%Reasonable earnings multiple · 15.23Manageable debt level · 0.05Healthy liquidity · 7.59
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Zack Debra
Transaction: 08/03/2026
BUY
Change
+162,311
Price
Not reported
Filing
08/06/2026
Type
BUY
Zack Debra
Transaction: 08/03/2026
BUY
Change
+324,675
Price
$1.54
Filing
08/06/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Zack Debra | OTHER | 0 | Not reported | 08/03/2026 | 08/06/2026 |
| Zack Debra | BUY | +162,311 | Not reported | 08/03/2026 | 08/06/2026 |
| Zack Debra | BUY | +324,675 | $1.54 | 08/03/2026 | 08/06/2026 |
| Pottage John C Jr | BUY | +20,000 | $2.15 | 06/23/2026 | 06/25/2026 |
| Pottage John C Jr | BUY | +10,000 | Not reported | 06/23/2026 | 06/25/2026 |
| Jackson Scott Thomas | BUY | +20,000 | $2.15 | 06/23/2026 | 06/25/2026 |
| Jackson Scott Thomas | BUY | +10,000 | Not reported | 06/23/2026 | 06/25/2026 |
| THOMAS FRANK E | BUY | +20,000 | $2.15 | 06/23/2026 | 06/25/2026 |
| THOMAS FRANK E | BUY | +10,000 | Not reported | 06/23/2026 | 06/25/2026 |
| VINK PATRICK V.J.J. | BUY | +20,000 | $2.15 | 06/23/2026 | 06/25/2026 |
| VINK PATRICK V.J.J. | BUY | +10,000 | Not reported | 06/23/2026 | 06/25/2026 |
| Smith Cynthia | BUY | +20,000 | $2.15 | 06/23/2026 | 06/25/2026 |
| Smith Cynthia | BUY | +10,000 | Not reported | 06/23/2026 | 06/25/2026 |
| Tregoning Kathleen | BUY | +20,000 | $2.15 | 06/23/2026 | 06/25/2026 |
| Tregoning Kathleen | BUY | +10,000 | Not reported | 06/23/2026 | 06/25/2026 |
| Deshpande Milind | BUY | +20,000 | $2.15 | 06/23/2026 | 06/25/2026 |
| Deshpande Milind | BUY | +10,000 | Not reported | 06/23/2026 | 06/25/2026 |
| Rajavelu Esther | SELL | -25,240 | $2.51 | 05/04/2026 | 05/06/2026 |
| Keutzer Timothy | SELL | -18,652 | $2.36 | 02/06/2026 | 02/09/2026 |
| Rajavelu Esther | SELL | -50,816 | $2.36 | 02/06/2026 | 02/09/2026 |